Astrana Health, Inc.
- Stock
- Ticker ASTH
- ISIN US03763A2078
- Nasdaq
Performance, volatility and drawdowns of Astrana Health, Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $68,322. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −84.8% in 02/2026, measured from the peak in 11/2021. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 665 | 620 | 655 | 956 | 951 | 965 | 973 | 1,024 |
| Operating income | 0.7 | 21 | 20 | 19 | 18 | 29 | 34 | 40 |
| EBITDA | 8.8 | 27 | 27 | 35 | 35 | 44 | 50 | 56 |
| Net income | -7.0 | 6.7 | 9.4 | 0.4 | 6.0 | 14 | 20 | 13 |
| Earnings per share | -0.14 | 0.14 | 0.19 | 0.01 | 0.13 | 0.29 | 0.40 | 0.26 |
| Balance sheet | ||||||||
| Total assets | 1,355 | 1,331 | 1,442 | 2,237 | 2,219 | 2,359 | 2,282 | 2,343 |
| Liabilities | 841 | 814 | 904 | 1,682 | 1,660 | 1,781 | 1,684 | 1,712 |
| Equity | 713 | 745 | 765 | 776 | 779 | 800 | 830 | 857 |
| Cash | 288 | 259 | 340 | 462 | 429 | 478 | 401 | 396 |
| Long-term debt | 425 | 404 | 401 | 1,002 | 991 | 980 | 883 | 866 |
| Cash flow | ||||||||
| Operating cash flow | -11 | 17 | 91 | 10.0 | -2.9 | 68 | 33 | 16 |
| Capital expenditure | -2.5 | -3.1 | -1.4 | -2.6 | -3.1 | -4.0 | -3.9 | -3.8 |
| Free cash flow | -13 | 14 | 89 | 7.4 | -6.0 | 64 | 29 | 12 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2021 at +302.2%, weakest 2022 at −59.7%. 3 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 6 Nov 2026 | $0.26 |
| 10 Aug 2026 | $0.40 |
| 8 May 2026 | $0.29 |
| 12 Mar 2026 | $0.13 |
| 10 Nov 2025 | $0.01 |
| 7 Aug 2025 | $0.19 |
| 9 May 2025 | $0.14 |
| 14 Mar 2025 | −$0.14 |
| 12 Nov 2024 | $0.33 |
| 9 Aug 2024 | $0.40 |
| 9 May 2024 | $0.31 |
| 29 Feb 2024 | $0.26 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €1.5bn
- Market cap in trading currency
- $1.61bn
- Enterprise value
- $2.14bn
- P/E
- 26.8
- P/S
- 0.41
- P/B
- 1.88
- EV/Sales
- 0.55
- EV/EBITDA
- 11.6
- Earnings yield
- 3.7%
- FCF yield
- 6.2%
Results (last four quarters)
- Revenue
- $3.91bn
- Gross profit
- –
- EBITDA
- $184m
- Net income
- $53.1m
- Earnings per share
- $1.08
- Revenue per share
- $70.10
- Revenue growth
- +7.1%
- Earnings growth
- +3,372.4%
Profitability
- Gross margin
- –
- Operating margin
- 3.1%
- Net margin
- 1.4%
- Return on equity
- 6.5%
- Return on assets
- 2.3%
Balance sheet and cash flow
- Cash
- $396m
- Cash per share
- $7.10
- Financial debt
- $925m
- Debt/equity %
- 108
- Current ratio
- 1.25
- Book value per share
- $15.35
- Operating cash flow
- $114m
- Free cash flow
- $99.4m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- 0%
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 55.8m
- Volume
- 440,984
- Avg. volume 3 months
- 371,209
- Relative volume
- 1.2
Price and technicals
- Price
- $28.90
- 1 day
- +0.8%
- 52-week high
- $49.81
- 52-week low
- $18.16
- Distance to 52-week high
- −42.0%
- Distance to 52-week low
- +59.1%
- Distance to 50-day line
- −18.9%
- Distance to 200-day line
- −16.3%
- RSI (14)
- 30
- Volatility 1M
- 63.1%
Performance
- 1 week
- −9.1%
- 1 month
- −24.0%
- 3 months
- −24.2%
- 6 months
- −23.6%
- YTD
- +16.5%
- 1 year
- +31.2%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has ASTH performed since 11/2016?
$10,000 grew to $68,322 by 20 Nov 2026, which is +21.2% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is ASTH?
Volatility was 150.9% per year, measured on monthly returns. The largest decline from a peak was −84.8%, with the low in 02/2026.
How does ASTH compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, ASTH returned +21.2% at 150.9%. The correlation of monthly returns was 0.10; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.